Elective

HR Professionals Can Now Earn Professional Development Credits for SHRM, HRPA, and HRCI with McLean & Company's Research-Driven Webinars

Retrieved on: 
Thursday, February 1, 2024

The global HR research and advisory firm's webinars are available at no cost, making obtaining professional development recertification credits easy and accessible.

Key Points: 
  • The global HR research and advisory firm's webinars are available at no cost, making obtaining professional development recertification credits easy and accessible.
  • To support HR professionals on their continuing education journeys, global HR research and advisory firm McLean & Company is pleased to announce new opportunities to earn pre-approved SHRM, HRPA, and HRCI professional development recertification credits through completion of the firm's data-driven webinars.
  • Now, with pre-approved professional development credits from SHRM, HRPA, and HRCI, they more formally lend themselves to driving ongoing professional development and recertification for the HR professionals of the future."
  • McLean & Company members also enjoy access to additional professional development opportunities and resources through McLean Academy , a self-paced eLearning program for HR professionals.

Device Companies will Drive Surgery Automation to Increase Elective Procedures in Western Europe

Retrieved on: 
Monday, June 7, 2021

After the outbreak, the Western European selective medical devices market for elective procedures is expected to reach $16.8 billion by 2023 at an aspirational compound annual growth rate (CAGR) of 29.2%.

Key Points: 
  • After the outbreak, the Western European selective medical devices market for elective procedures is expected to reach $16.8 billion by 2023 at an aspirational compound annual growth rate (CAGR) of 29.2%.
  • Training for Precision Surgery: Data will enable device companies to support automation that will enable physicians to have assists during a robot-assisted surgery.
  • Medical device companies' data will enable partnerships and capabilities to help hospitals and health centers serve more patients.
  • Impact of COVID-19 on Elective Procedures in Western Europe, 20202023

Device Companies will Drive Surgery Automation to Increase Elective Procedures in Western Europe

Retrieved on: 
Monday, June 7, 2021

After the outbreak, the Western European selective medical devices market for elective procedures is expected to reach $16.8 billion by 2023 at an aspirational compound annual growth rate (CAGR) of 29.2%.

Key Points: 
  • After the outbreak, the Western European selective medical devices market for elective procedures is expected to reach $16.8 billion by 2023 at an aspirational compound annual growth rate (CAGR) of 29.2%.
  • Training for Precision Surgery: Data will enable device companies to support automation that will enable physicians to have assists during a robot-assisted surgery.
  • Medical device companies' data will enable partnerships and capabilities to help hospitals and health centers serve more patients.
  • Impact of COVID-19 on Elective Procedures in Western Europe, 20202023

Western European Elective Procedures Market 2020-2023 - Nearly 80% of Orthopedic Procedures in Europe have been Delayed, Postponed or Canceled Due to COVID-19

Retrieved on: 
Monday, April 19, 2021

b'DUBLIN, April 19, 2021 /PRNewswire/ -- The "Impact of COVID-19 on Elective Procedures in Western Europe, 2020-2023" report has been added to ResearchAndMarkets.com\'s offering.\nThe deferral of elective procedures due to pandemic-related measures has adversely affected the cardiovascular medical devices market.

Key Points: 
  • b'DUBLIN, April 19, 2021 /PRNewswire/ -- The "Impact of COVID-19 on Elective Procedures in Western Europe, 2020-2023" report has been added to ResearchAndMarkets.com\'s offering.\nThe deferral of elective procedures due to pandemic-related measures has adversely affected the cardiovascular medical devices market.
  • While some cardiovascular procedures are considered urgent, others have been rescheduled and deferred.\nNearly 80% of all the orthopedic procedures performed in Europe are estimated to have been delayed, postponed, or canceled due to COVID-19, as they are considered to be elective and non-essential procedures.
  • Traumas, amputations, and oncological procedures are considered to be the most essential.
  • Providers are witnessing a decrease in ambulatory care and elective surgeries, even as the infection is spreading in nursing homes.

Maastricht Univerisity Medical Center Commences Procedures

Retrieved on: 
Wednesday, February 24, 2021

Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided cardiac ablation products, is pleased to announce the Maastricht University Medical Centre+ (MUMC+) in the Netherlands has commenced procedures since the extended lockdowns across Europe precluded elective surgeries.

Key Points: 
  • Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided cardiac ablation products, is pleased to announce the Maastricht University Medical Centre+ (MUMC+) in the Netherlands has commenced procedures since the extended lockdowns across Europe precluded elective surgeries.
  • While we have just started in iCMR, it is obvious to see the future of this technology and where it will take us and patient treatment.
  • Imricors Chair and CEO, Steve Wedan, commented: This is great news and an exciting step forward, as we start to put COVID behind us.
  • We continue to actively plan for the easing of COVID restrictions, including scheduling training and installation at new sites and supporting the recommencement of procedures at existing sites.

Impact of COVID-19 on Elective Procedures in the United States, 2020 Report - Nearly 83.5% of All Orthopedic Procedures Performed have Been Delayed, Postponed, or Canceled

Retrieved on: 
Wednesday, January 20, 2021

DUBLIN, Jan. 20, 2021 /PRNewswire/ -- The "Impact of COVID-19 on Elective Procedures in the US, 2020-2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Jan. 20, 2021 /PRNewswire/ -- The "Impact of COVID-19 on Elective Procedures in the US, 2020-2023" report has been added to ResearchAndMarkets.com's offering.
  • The deferral of elective procedures due to COVID-19-related measures has affected the cardiovascular medical device market.
  • Nearly 83.5% of all orthopedic procedures performed in the United States have been delayed, postponed, or canceled since the COVID-19 outbreak, as they are considered to be elective and non-essential.
  • The top 10 procedures account for 62.5% percent of the total volume and include knee, hip, and shoulder replacements and spinal fusion procedures.

Impact of COVID-19 on Elective Procedures in the United States, 2020-2023 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 19, 2021

The "Impact of COVID-19 on Elective Procedures in the US, 2020-2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Impact of COVID-19 on Elective Procedures in the US, 2020-2023" report has been added to ResearchAndMarkets.com's offering.
  • The deferral of elective procedures due to COVID-19-related measures has affected the cardiovascular medical device market.
  • Nearly 83.5% of all orthopedic procedures performed in the United States have been delayed, postponed, or canceled since the COVID-19 outbreak, as they are considered to be elective and non-essential.
  • The top 10 procedures account for 62.5% percent of the total volume and include knee, hip, and shoulder replacements and spinal fusion procedures.

New Study Forecasts How COVID-19 Concerns May Affect Elective Procedures, Budgets and Hospital Access

Retrieved on: 
Tuesday, November 10, 2020

While hospitals are still experiencing a reduction in elective procedure volume, they are slowly beginning to see a return to pre-COVID-19 levels.

Key Points: 
  • While hospitals are still experiencing a reduction in elective procedure volume, they are slowly beginning to see a return to pre-COVID-19 levels.
  • The reduction in elective procedures, however, does cast a shadow on hospital operating and capital budgets which will ultimately impact vendors, facility headcount and necessitate new strategies to counter-effect revenue decline.
  • Craig Ackerman, principal and healthcare practice lead at Alexander Group, explains, When we look at elective procedures, they are currently at 80% of pre-COVID-19 levels.
  • Given the fact that elective procedures are down, its no surprise hospitals are cutting both capital and operating budgets, Ackerman stated.

VitalHub Subsidiary Transforming Systems Builds “SHREWD Elective Care Module” in Cooperation with NHS England

Retrieved on: 
Friday, October 16, 2020

TORONTO, Oct. 16, 2020 (GLOBE NEWSWIRE) -- VitalHub Corp. (the Company or VitalHub) (TSXV: VHI) is pleased to announce that recently acquired subsidiary, Transforming Systems, has developed an elective care module, SHREWD Elective, in cooperation with National Health Service (NHS) England.

Key Points: 
  • TORONTO, Oct. 16, 2020 (GLOBE NEWSWIRE) -- VitalHub Corp. (the Company or VitalHub) (TSXV: VHI) is pleased to announce that recently acquired subsidiary, Transforming Systems, has developed an elective care module, SHREWD Elective, in cooperation with National Health Service (NHS) England.
  • The Elective module was developed in response to the need of NHS England to manage the growing pressure in planned care across the country.
  • Having had such great success with the SHREWD Resilience module in our Urgent Care Pathway, we were eager to get involved when we were approached by NHS England to support the development of the SHREWD module for Elective Care.
  • Resource optimization, capacity planning, and patient flow management are essential in elective (or planned) care.

Sonata System Assists Facilities Impacted by the COVID-19 Pandemic in Restarting Elective Gynecologic Procedures

Retrieved on: 
Monday, June 22, 2020

Sonata is typically utilized in an outpatient setting or ambulatory surgery center (ASC) and does not require a hospital inpatient admission.

Key Points: 
  • Sonata is typically utilized in an outpatient setting or ambulatory surgery center (ASC) and does not require a hospital inpatient admission.
  • Sonata will be an important technology in support of the resumption of elective fibroid procedures in the wake of the COVID-19 pandemic.
  • The clinical and procedural benefits of the Sonata system provides a compelling value proposition for all stakeholders and may be an important technology in restarting and maintaining elective procedures for facilities impacted by the effects of the COVID-19 pandemic, said Christopher Owens, President & CEO of Gynesonics.
  • These factors all contribute to why we prioritized patients desiring Sonata when restarting elective procedures.